These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24315369)

  • 1. TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.
    Lourenco MV; Clarke JR; Frozza RL; Bomfim TR; Forny-Germano L; Batista AF; Sathler LB; Brito-Moreira J; Amaral OB; Silva CA; Freitas-Correa L; Espírito-Santo S; Campello-Costa P; Houzel JC; Klein WL; Holscher C; Carvalheira JB; Silva AM; Velloso LA; Munoz DP; Ferreira ST; De Felice FG
    Cell Metab; 2013 Dec; 18(6):831-43. PubMed ID: 24315369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteostasis impairment: at the intersection between Alzheimer's disease and diabetes.
    Medinas DB; Hetz C
    Cell Metab; 2013 Dec; 18(6):771-2. PubMed ID: 24315366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
    Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
    J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
    Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
    J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.
    Mouton-Liger F; Paquet C; Dumurgier J; Bouras C; Pradier L; Gray F; Hugon J
    Biochim Biophys Acta; 2012 Jun; 1822(6):885-96. PubMed ID: 22306812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes.
    Lourenco MV; Ferreira ST; De Felice FG
    Prog Neurobiol; 2015 Jun; 129():37-57. PubMed ID: 25857551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions.
    Tible M; Mouton Liger F; Schmitt J; Giralt A; Farid K; Thomasseau S; Gourmaud S; Paquet C; Rondi Reig L; Meurs E; Girault JA; Hugon J
    Aging Cell; 2019 Jun; 18(3):e12887. PubMed ID: 30821420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Selective PKR Inhibitor Restores Cognitive Deficits and Neurodegeneration in Alzheimer Disease Experimental Models.
    Lopez-Grancha M; Bernardelli P; Moindrot N; Genet E; Vincent C; Roudieres V; Krick A; Sabuco JF; Machnik D; Ibghi D; Pradier L; Taupin V
    J Pharmacol Exp Ther; 2021 Sep; 378(3):262-275. PubMed ID: 34531308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.
    Montgomery SL; Mastrangelo MA; Habib D; Narrow WC; Knowlden SA; Wright TW; Bowers WJ
    Am J Pathol; 2011 Oct; 179(4):2053-70. PubMed ID: 21835156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity.
    Suen KC; Yu MS; So KF; Chang RC; Hugon J
    J Biol Chem; 2003 Dec; 278(50):49819-27. PubMed ID: 12975376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrodin suppresses BACE1 expression under oxidative stress condition via inhibition of the PKR/eIF2α pathway in Alzheimer's disease.
    Zhang JS; Zhou SF; Wang Q; Guo JN; Liang HM; Deng JB; He WY
    Neuroscience; 2016 Jun; 325():1-9. PubMed ID: 26987953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring synaptic plasticity and memory in mouse models of Alzheimer's disease by PKR inhibition.
    Hwang KD; Bak MS; Kim SJ; Rhee S; Lee YS
    Mol Brain; 2017 Dec; 10(1):57. PubMed ID: 29233183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration.
    Chang RC; Suen KC; Ma CH; Elyaman W; Ng HK; Hugon J
    J Neurochem; 2002 Dec; 83(5):1215-25. PubMed ID: 12437593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease.
    Devi L; Ohno M
    PLoS One; 2013; 8(10):e77335. PubMed ID: 24146979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic copper exposure causes spatial memory impairment, selective loss of hippocampal synaptic proteins, and activation of PKR/eIF2α pathway in mice.
    Ma Q; Ying M; Sui X; Zhang H; Huang H; Yang L; Huang X; Zhuang Z; Liu J; Yang X
    J Alzheimers Dis; 2015; 43(4):1413-27. PubMed ID: 25159668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation.
    Clarke JR; Lyra E Silva NM; Figueiredo CP; Frozza RL; Ledo JH; Beckman D; Katashima CK; Razolli D; Carvalho BM; Frazão R; Silveira MA; Ribeiro FC; Bomfim TR; Neves FS; Klein WL; Medeiros R; LaFerla FM; Carvalheira JB; Saad MJ; Munoz DP; Velloso LA; Ferreira ST; De Felice FG
    EMBO Mol Med; 2015 Feb; 7(2):190-210. PubMed ID: 25617315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.
    He P; Zhong Z; Lindholm K; Berning L; Lee W; Lemere C; Staufenbiel M; Li R; Shen Y
    J Cell Biol; 2007 Aug; 178(5):829-41. PubMed ID: 17724122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKR downregulation prevents neurodegeneration and β-amyloid production in a thiamine-deficient model.
    Mouton-Liger F; Rebillat AS; Gourmaud S; Paquet C; Leguen A; Dumurgier J; Bernadelli P; Taupin V; Pradier L; Rooney T; Hugon J
    Cell Death Dis; 2015 Jan; 6(1):e1594. PubMed ID: 25590804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition.
    Wuerth JD; Habjan M; Kainulainen M; Berisha B; Bertheloot D; Superti-Furga G; Pichlmair A; Weber F
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
    Batista AF; Forny-Germano L; Clarke JR; Lyra E Silva NM; Brito-Moreira J; Boehnke SE; Winterborn A; Coe BC; Lablans A; Vital JF; Marques SA; Martinez AM; Gralle M; Holscher C; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Pathol; 2018 May; 245(1):85-100. PubMed ID: 29435980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.